Xynomic Pharma Files For $65 Million Offering

Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on NASDAQ under the symbol “XYN.”